Literature DB >> 8663294

ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B.

H Duan1, K Orth, A M Chinnaiyan, G G Poirier, C J Froelich, W W He, V M Dixit.   

Abstract

Members of the ICE/Ced-3 gene family are likely effector components of the cell death machinery. Here, we characterize a novel member of this family designated ICE-LAP6. By phylogenetic analysis, ICE-LAP6 is classified into the Ced-3 subfamily which includes Ced-3, Yama/CPP32/apopain, Mch2, and ICE-LAP3/Mch3/CMH-1. Interestingly, ICE-LAP6 contains an active site QACGG pentapeptide, rather than the QACRG pentapeptide shared by other family members. Overexpression of ICE-LAP6 induces apoptosis in MCF7 breast carcinoma cells. More importantly, ICE-LAP6 is proteolytically processed into an active cysteine protease by granzyme B, an important component of cytotoxic T cell-mediated apoptosis. Once activated, ICE-LAP6 is able to cleave the death substrate poly(ADP-ribose) polymerase into signature apoptotic fragments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663294     DOI: 10.1074/jbc.271.28.16720

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them.

Authors:  P J Beresford; C M Kam; J C Powers; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death.

Authors:  D K Han; P M Chaudhary; M E Wright; C Friedman; B J Trask; R T Riedel; D G Baskin; S M Schwartz; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 4.  Apoptosis: a new pharmacodynamic endpoint.

Authors:  J L Au; N Panchal; D Li; Y Gan
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

5.  Identification of estrogen-responsive genes in neuroblastoma SK-ER3 cells.

Authors:  M Garnier; D Di Lorenzo; A Albertini; A Maggi
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

6.  Activation of CPP32 and Mch3 alpha in wild-type p53-induced apoptosis.

Authors:  J M Chandler; E S Alnemri; G M Cohen; M MacFarlane
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

Review 7.  Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis.

Authors:  C A Casiano; E M Tan
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

Review 8.  Pharmacogenetic biomarkers of response in Crohn's disease.

Authors:  T M Linares-Pineda; M Cañadas-Garre; A Sánchez-Pozo; M Á Calleja-Hernández
Journal:  Pharmacogenomics J       Date:  2017-06-20       Impact factor: 3.550

9.  Apoptosis induction by interleukin-2-activated cytotoxic lymphocytes in a squamous cell carcinoma cell line and Daudi cells - involvement of reactive oxygen species-dependent cytochrome c and reactive oxygen species-independent apoptosis-inducing factors.

Authors:  Tetsuya Yamamoto; Eisaku Ueta; Tokio Osaki
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

10.  Lrcasp9 shares similarity in structural motifs with human caspase-9 and is activated following bacterial infection and anti-viral vaccination.

Authors:  Alok Kumar Giri; Mahismita Paichha; Ashis Saha; Surajit Das; Mrinal Samanta
Journal:  3 Biotech       Date:  2018-07-27       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.